MedPath

DANTROLENE SODIUM FOR INJECTION, USP

DANTROLENE SODIUM FOR INJECTION, USP

Approved
DIN Number

02529998

Drug Class

Human

Market Date

Mar 29, 2023

Company
HC

hikma canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02529998
AIG Number0109855003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M03CA01 DANTROLENE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification12:20.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

DANTROLENE SODIUMActive
Strength: 20 MG / VIAL
Monograph: DANTROLENE SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.